Annual CFI
$4.93 M
+$9.85 M+200.19%
31 December 2023
Summary:
Monopar Therapeutics annual cash flow from investing activities is currently $4.93 million, with the most recent change of +$9.85 million (+200.19%) on 31 December 2023. MNPR annual CFI is now at all-time high.MNPR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$985.70 K
+$988.10 K+41170.83%
30 September 2024
Summary:
Monopar Therapeutics quarterly cash flow from investing activities is currently $985.70 thousand, with the most recent change of +$988.10 thousand (+41170.83%) on 30 September 2024. Over the past year, it has increased by +$998.80 thousand (+7624.43%). MNPR quarterly CFI is now -66.82% below its all-time high of $2.97 million, reached on 31 December 2023.MNPR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$2.97 M
+$998.80 K+50.66%
30 September 2024
Summary:
Monopar Therapeutics TTM cash flow from investing activities is currently $2.97 million, with the most recent change of +$998.80 thousand (+50.66%) on 30 September 2024. Over the past year, it has increased by +$5.93 million (+200.31%). MNPR TTM CFI is now -39.72% below its all-time high of $4.93 million, reached on 31 March 2024.MNPR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +200.2% | +7624.4% | +200.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MNPR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +200.2% | -66.8% | +120.0% | -39.7% | +150.3% |
| 5 y | 5 years | at high | +200.2% | -66.8% | +120.0% | -39.7% | +150.3% |
| alltime | all time | at high | +200.2% | -66.8% | +120.0% | -39.7% | +150.3% |
Monopar Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $985.70 K(<-9900.0%) | $2.97 M(+50.7%) |
| June 2024 | - | -$2400.00(-99.8%) | $1.97 M(-60.0%) |
| Mar 2024 | - | -$983.30 K(-133.1%) | $4.93 M(+0.0%) |
| Dec 2023 | $4.93 M | $2.97 M(<-9900.0%) | $4.93 M(-266.4%) |
| Sept 2023 | - | -$13.10 K(-100.4%) | -$2.96 M(+0.4%) |
| June 2023 | - | $2.95 M(-400.4%) | -$2.95 M(-50.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$983.40 K(-80.0%) | -$5.90 M(+20.0%) |
| Dec 2022 | -$4.92 M(<-9900.0%) | -$4.92 M(<-9900.0%) | -$4.92 M(<-9900.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00 | $0.00 |
| Dec 2021 | $0.00 | - | - |
FAQ
- What is Monopar Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Monopar Therapeutics?
- What is Monopar Therapeutics annual CFI year-on-year change?
- What is Monopar Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly CFI year-on-year change?
- What is Monopar Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Monopar Therapeutics?
- What is Monopar Therapeutics TTM CFI year-on-year change?
What is Monopar Therapeutics annual cash flow from investing activities?
The current annual CFI of MNPR is $4.93 M
What is the all time high annual CFI for Monopar Therapeutics?
Monopar Therapeutics all-time high annual cash flow from investing activities is $4.93 M
What is Monopar Therapeutics annual CFI year-on-year change?
Over the past year, MNPR annual cash flow from investing activities has changed by +$9.85 M (+200.19%)
What is Monopar Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of MNPR is $985.70 K
What is the all time high quarterly CFI for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly cash flow from investing activities is $2.97 M
What is Monopar Therapeutics quarterly CFI year-on-year change?
Over the past year, MNPR quarterly cash flow from investing activities has changed by +$998.80 K (+7624.43%)
What is Monopar Therapeutics TTM cash flow from investing activities?
The current TTM CFI of MNPR is $2.97 M
What is the all time high TTM CFI for Monopar Therapeutics?
Monopar Therapeutics all-time high TTM cash flow from investing activities is $4.93 M
What is Monopar Therapeutics TTM CFI year-on-year change?
Over the past year, MNPR TTM cash flow from investing activities has changed by +$5.93 M (+200.31%)